Last $125.21 USD
Change Today -2.75 / -2.15%
Volume 3.5M
TMO On Other Exchanges
As of 8:04 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

thermo fisher scientific inc (TMO) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/9/15 - $131.12
52 Week Low
10/15/14 - $107.33
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

thermo fisher scientific inc (TMO) Details

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics in the United States and internationally. It operates in three segments: Analytical Technologies; Specialty Diagnostics; and Laboratory Products and Services. The Analytical Technologies segment offers instruments, reagents, consumables, software, and services for applications in the laboratory, on the production line, and in the field. It serves pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as the clinical laboratory. The Specialty Diagnostics segment provides various diagnostic test kits, reagents, culture media, instruments, and associated products for customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. This segment offers blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, controls, and calibration verification fluids; human leukocyte antigen typing and testing for the organ transplant; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; and products for cancer diagnosis and medical research in histology, cytology, and hematology applications. The Laboratory Products and Services segment offers sample preparation and preservation equipment, cold storage equipment, centrifugation products, biological safety cabinets, temperature control products, water analysis instruments, and other laboratory equipment, as well as laboratory consumables, research and safety market solutions, and biopharma services. The company has a strategic collaboration with Samsung Electronics Co. Ltd. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

50,000 Employees
Last Reported Date: 01/29/15
Founded in 1956

thermo fisher scientific inc (TMO) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $1.1M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $653.7K
Executive Vice President and President of Lab...
Total Annual Compensation: $697.9K
Senior Vice President and President of Analyt...
Total Annual Compensation: $514.1K
Chief Commercial Officer and Senior Vice Pres...
Total Annual Compensation: $622.6K
Compensation as of Fiscal Year 2013.

thermo fisher scientific inc (TMO) Key Developments

Thermo Fisher Scientific Inc. Unveils a New Series of mySPIN Mini Centrifuge

Thermo Fisher Scientific Inc. has unveiled a new series of mySPIN mini centrifuges. The Thermo Scientific mySPIN mini centrifuges are designed for protocols requiring quick spin downs, micro-filter cell separations and HPLC samples as well as applications with a higher RCF requirement. The Thermo Scientific mySPIN 6 and mySPIN 12 mini centrifuges combine speed with flexibility, allowing researchers to easily perform fast spins within 20-30 seconds. In addition, the mySPIN 6 and 12 mini centrifuges feature a compact, ergonomic design to fit personal workstations for daily applications as well as an intuitive display for easy operation. The mySPIN mini centrifuges also offer: Tool-free rotor exchange; Brush-less motor for quiet operation and low vibration; Standard safety features for customer assurance; and Maximum speeds up to 6,000 rpm (mySPIN 6 mini centrifuge) and 12,500 rpm (mySPIN 12 mini centrifuge).

Thermo Fisher Scientific Inc. Launches Next-Generation Sequencing Cancer Research Panel

Thermo Fisher Scientific Inc. has launched a next-generation sequencing (NGS), Ion Torrent AmpliSeq RNA Fusion Lung Cancer Research Panel for targeted sequencing of fusion transcripts for clinical research. The new Ion Torrent AmpliSeq RNA Fusion Lung Cancer Research Panel allows simultaneous sequencing of 70 ALK, RET, ROS1, and NTRK1 fusion transcripts associated with lung cancer as well as 5' and 3' ALK gene expression. Based on Ion Torrent AmpliSeq technology, the NGS fusion detection workflow was designed for simplicity of use and high performance using as little as 10ng of FFPE derived RNA. With the increasing importance of genetic translocations in oncology, the Ion Torrent AmpliSeq RNA Fusion Lung Cancer Research Panel can be used in conjunction with the Ion Torrent AmpliSeq Colon and Lung Cancer Research Panel v2 to obtain a complete view of mutations from even the most limiting lung tissue FFPE samples and fine needle aspirates. The overall approach reduces the cost and risk of sample consumption associated with performing multiple sequential tests as well as the laboratory complexity associated with alternative fusion detection methods such as FISH. The targeted sequencing approach demonstrates high concordance with traditional fusion detection methods, including FISH, ICH, and qPCR. By focusing the sequencing on the fusion junctions, it increases the depth of sequencing on informative regions, enabling higher sensitivity of detection. Integrated with Ion Reporter Software, the application includes easy-to-use fusion reporting and visualization tools for fusion classification.

Thermo Fisher Scientific Inc. Releases New CE-IVD Solid Tumor DNA Kit

Thermo Fisher Scientific Inc. has released new CE-IVD Oncomine solid tumor DNA kit for multiplexed sequencing of formalin-fixed, paraffin embedded (FFPE), tumor samples. Compared to other molecular diagnostic testing methods, such as qPCR or Sanger sequencing, next-generation sequencing (NGS) can assess a broader range of genes in a single test. Based on the Ion Torrent AmpliSeq Technology, the kit allows detection of single nucleotide somatic changes, inversions, insertions, and deletions using as little as 10ng of FFPE DNA, enabling laboratory clinicians to analyze samples that may contain partially degraded or limited tumor material, and generate reportable results from more samples than previously possible with lower acceptance thresholds for FFPE tumor DNA. The panel was verified by leading clinicians from the OncoNetwork Consortium with a focus on colon and lung cancer. Marked for in vitro diagnostic use in the European Union, the kit captures regions of human somatic variants (deletions, insertions, inversions, and substitutions) present in selected regions of cancer-related genes (EGFR, ALK, ERBB2, ERBB4, FGFR1, FGFR2, FGFR3, MET, DDR2, KRAS, PIK3CA, BRAF, AKT1, PTEN, NRAS, MAP2K1, STK11, NOTCH1, CTNNB1, SMAD4, FBXW7, TP53) for analysis using NGS technology.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TMO:US $125.21 USD -2.75

TMO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akzo Nobel NV €64.12 EUR -0.16
Corning Inc $23.77 USD -0.02
Danaher Corp $82.38 USD -1.55
General Dynamics Corp $133.21 USD -1.27
Safran SA €59.19 EUR -0.55
View Industry Companies

Industry Analysis


Industry Average

Valuation TMO Industry Range
Price/Earnings 26.6x
Price/Sales 3.0x
Price/Book 2.4x
Price/Cash Flow 15.5x
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERMO FISHER SCIENTIFIC INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at